Position
Parallel Advisors, LLC in 10x Genomics, Inc.
Back to the book · All holders of TXG
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $12.6K$16.31 → $21.23
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.56K | $41.8K | — | — | — | 0.0% |
| Q1 2026 | 2.56K | $54.4K | $21.23 | $12.6K | −$0 | 0.0% |